Raymond J. Henley Iii

Array ( [id] => 4408851 [patent_doc_number] => 06239128 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Indole-2,3-dione-3-oxime derivatives for therapeutic use' [patent_app_type] => 1 [patent_app_number] => 9/675214 [patent_app_country] => US [patent_app_date] => 2000-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12172 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 392 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/239/06239128.pdf [firstpage_image] =>[orig_patent_app_number] => 675214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1500948 [patent_doc_number] => 06486168 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-26 [patent_title] => 'Formulations and methods for treatment of mucosal associated conditions with an immune response modifier' [patent_app_type] => B1 [patent_app_number] => 09/676339 [patent_app_country] => US [patent_app_date] => 2000-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 9364 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/486/06486168.pdf [firstpage_image] =>[orig_patent_app_number] => 09676339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1553850 [patent_doc_number] => 06348465 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-19 [patent_title] => 'Fructosamine oxidase: antagonists and inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/671967 [patent_app_country] => US [patent_app_date] => 2000-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9336 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/348/06348465.pdf [firstpage_image] =>[orig_patent_app_number] => 09671967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 637942 [patent_doc_number] => 07125897 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-24 [patent_title] => 'Combined therapies for atherosclerosis treatment' [patent_app_type] => utility [patent_app_number] => 10/089362 [patent_app_country] => US [patent_app_date] => 2000-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6540 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/125/07125897.pdf [firstpage_image] =>[orig_patent_app_number] => 10089362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410384 [patent_doc_number] => 06310100 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Method of treating hypertension' [patent_app_type] => 1 [patent_app_number] => 9/667794 [patent_app_country] => US [patent_app_date] => 2000-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3858 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310100.pdf [firstpage_image] =>[orig_patent_app_number] => 667794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4282479 [patent_doc_number] => 06267992 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Treatment of diabetic nephropathy and microalbuminuria' [patent_app_type] => 1 [patent_app_number] => 9/666623 [patent_app_country] => US [patent_app_date] => 2000-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 10622 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/267/06267992.pdf [firstpage_image] =>[orig_patent_app_number] => 666623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1441327 [patent_doc_number] => 06335368 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-01 [patent_title] => 'Use of alverine for reducing wrinkles' [patent_app_type] => B1 [patent_app_number] => 09/666343 [patent_app_country] => US [patent_app_date] => 2000-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3001 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/335/06335368.pdf [firstpage_image] =>[orig_patent_app_number] => 09666343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4311897 [patent_doc_number] => 06316431 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents' [patent_app_type] => 1 [patent_app_number] => 9/581128 [patent_app_country] => US [patent_app_date] => 2000-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 8077 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316431.pdf [firstpage_image] =>[orig_patent_app_number] => 581128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4252905 [patent_doc_number] => 06207714 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Methods and pharmaceutical preparations for improving glucose metabolism with (-)-hydroxycitric acid' [patent_app_type] => 1 [patent_app_number] => 9/661588 [patent_app_country] => US [patent_app_date] => 2000-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2611 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207714.pdf [firstpage_image] =>[orig_patent_app_number] => 661588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1504197 [patent_doc_number] => 06465463 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-15 [patent_title] => 'Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate' [patent_app_type] => B1 [patent_app_number] => 09/658261 [patent_app_country] => US [patent_app_date] => 2000-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9323 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/465/06465463.pdf [firstpage_image] =>[orig_patent_app_number] => 09658261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4331429 [patent_doc_number] => 06313155 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Composition and method for treating macular disorders' [patent_app_type] => 1 [patent_app_number] => 9/656585 [patent_app_country] => US [patent_app_date] => 2000-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 7483 [patent_no_of_claims] => 106 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/313/06313155.pdf [firstpage_image] =>[orig_patent_app_number] => 656585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4320896 [patent_doc_number] => 06248774 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Method for treating hyper-excited sensory nerve functions in humans' [patent_app_type] => 1 [patent_app_number] => 9/654994 [patent_app_country] => US [patent_app_date] => 2000-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5904 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248774.pdf [firstpage_image] =>[orig_patent_app_number] => 654994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4305788 [patent_doc_number] => 06326400 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester and its derivatives for appetite enhancement' [patent_app_type] => 1 [patent_app_number] => 9/648357 [patent_app_country] => US [patent_app_date] => 2000-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8289 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326400.pdf [firstpage_image] =>[orig_patent_app_number] => 648357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4277477 [patent_doc_number] => 06281222 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Compositions and method for treatment of acetaminophen intoxication' [patent_app_type] => 1 [patent_app_number] => 9/641249 [patent_app_country] => US [patent_app_date] => 2000-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 4051 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/281/06281222.pdf [firstpage_image] =>[orig_patent_app_number] => 641249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4383535 [patent_doc_number] => 06262062 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Method of treating the syndrome of coronary heart disease risk factors in humans' [patent_app_type] => 1 [patent_app_number] => 9/639061 [patent_app_country] => US [patent_app_date] => 2000-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5010 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262062.pdf [firstpage_image] =>[orig_patent_app_number] => 639061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4304991 [patent_doc_number] => 06251935 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Treatment of migraine by administration of .alpha.-lipoic acid or derivatives thereof' [patent_app_type] => 1 [patent_app_number] => 9/638034 [patent_app_country] => US [patent_app_date] => 2000-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2371 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251935.pdf [firstpage_image] =>[orig_patent_app_number] => 638034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4272668 [patent_doc_number] => 06323192 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Chromium polynicotinate compositions and uses thereof for absorption of essential metals' [patent_app_type] => 1 [patent_app_number] => 9/634664 [patent_app_country] => US [patent_app_date] => 2000-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3527 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/323/06323192.pdf [firstpage_image] =>[orig_patent_app_number] => 634664 [rel_patent_id] =>[rel_patent_doc_number] =>)